NEUROVANCE Trademark

Trademark Overview

On Wednesday, November 4, 2009, a trademark application was filed for NEUROVANCE with the United States Patent and Trademark Office. The USPTO has given the NEUROVANCE trademark a serial number of 77864680. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 16, 2019. This trademark is owned by Euthymics Bioscience, Inc.. The NEUROVANCE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Laboratory research in the field of treatment and or prophylaxis of disorders of the central nervous system; Pharmaceutical research and development; Pharmaceutical research services; Research and development of technology in the field of drug discovery, pharmaceuticals, all related to the treatment of disorders of the central nervous system
neurovance

General Information

Serial Number77864680
Word MarkNEUROVANCE
Filing DateWednesday, November 4, 2009
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 16, 2019
Registration Number4276086
Registration DateTuesday, January 15, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 6, 2010

Trademark Statements

Goods and ServicesLaboratory research in the field of treatment and or prophylaxis of disorders of the central nervous system; Pharmaceutical research and development; Pharmaceutical research services; Research and development of technology in the field of drug discovery, pharmaceuticals, all related to the treatment of disorders of the central nervous system
Pseudo MarkNEURON ADVANCE

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 16, 2019
Primary Code042
First Use Anywhere DateThursday, October 18, 2012
First Use In Commerce DateThursday, October 18, 2012

Trademark Owner History

Party NameNEUROVANCE, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02141
Party NameEuthymics Bioscience, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141
Party NameEuthymics Bioscience, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141
Party NameEuthymics Bioscience, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDel Mar, CA 92014

Trademark Events

Event DateEvent Description
Friday, August 16, 2019CANCELLED SEC. 8 (6-YR)
Monday, January 15, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, May 10, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, January 15, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, December 11, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, December 10, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, December 10, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, December 3, 2012STATEMENT OF USE PROCESSING COMPLETE
Thursday, November 29, 2012USE AMENDMENT FILED
Thursday, November 29, 2012TEAS STATEMENT OF USE RECEIVED
Saturday, May 12, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 11, 2012EXTENSION 4 GRANTED
Sunday, May 6, 2012EXTENSION 4 FILED
Sunday, May 6, 2012TEAS EXTENSION RECEIVED
Thursday, December 1, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 30, 2011EXTENSION 3 GRANTED
Friday, November 25, 2011EXTENSION 3 FILED
Friday, November 25, 2011TEAS EXTENSION RECEIVED
Tuesday, May 10, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 9, 2011EXTENSION 2 GRANTED
Thursday, May 5, 2011EXTENSION 2 FILED
Thursday, May 5, 2011TEAS EXTENSION RECEIVED
Wednesday, December 1, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 30, 2010EXTENSION 1 GRANTED
Monday, November 15, 2010EXTENSION 1 FILED
Monday, November 29, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 15, 2010TEAS EXTENSION RECEIVED
Friday, November 12, 2010APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, November 12, 2010TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 1, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 6, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 6, 2010PUBLISHED FOR OPPOSITION
Thursday, March 4, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, March 4, 2010ASSIGNED TO LIE
Tuesday, February 9, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 9, 2010ASSIGNED TO EXAMINER
Friday, November 13, 2009NOTICE OF PSEUDO MARK MAILED
Thursday, November 12, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, November 7, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

neurovance research nervous pharmaceutical development central system disorders field treatment discovery